What are the recommended treatment regimens and dosages for H. pylori infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

H. pylori Treatment Regimens and Dosages

Bismuth quadruple therapy for 14 days is the preferred first-line treatment for H. pylori infection, consisting of a PPI twice daily, bismuth subsalicylate 524 mg (or 262 mg as 2 tablets) four times daily, metronidazole 500 mg three to four times daily (total 1.5-2 g daily), and tetracycline 500 mg four times daily. 1, 2, 3

First-Line Treatment Options

Bismuth Quadruple Therapy (Preferred)

  • PPI (high-dose): Esomeprazole or rabeprazole 40 mg twice daily, taken 30 minutes before meals on an empty stomach 1, 2
  • Bismuth subsalicylate: 524 mg four times daily (or 262 mg as 2 tablets four times daily) 1, 3
  • Metronidazole: 500 mg three to four times daily (total daily dose 1.5-2 g) 1, 2, 3
  • Tetracycline: 500 mg four times daily 1, 2
  • Duration: 14 days (mandatory to maximize eradication rates of 80-90%) 1, 2, 4

This regimen is preferred because bacterial resistance to bismuth is extremely rare, and it achieves high eradication rates even against strains resistant to clarithromycin and metronidazole. 1, 2, 3

Alternative First-Line: Concomitant Non-Bismuth Quadruple Therapy

  • PPI (high-dose): Twice daily 1, 2
  • Amoxicillin: 1000 mg twice daily 1, 2, 5
  • Clarithromycin: 500 mg twice daily 1, 2
  • Metronidazole: 500 mg twice daily 1, 2
  • Duration: 14 days 1, 2

This regimen should only be used when bismuth is unavailable, as it includes clarithromycin which has increasing resistance rates globally (>15-20% in most regions). 1, 2

Triple Therapy (Only in Low Clarithromycin Resistance Areas <15%)

  • PPI (high-dose): Twice daily 1, 2
  • Amoxicillin: 1000 mg twice daily 1, 2, 5
  • Clarithromycin: 500 mg twice daily 1, 2
  • Duration: 14 days 1, 2

Critical caveat: This regimen should be abandoned in most North American and European regions where clarithromycin resistance now exceeds 15%, as eradication rates drop to only 20% with resistant strains compared to 90% with susceptible strains. 1, 2

Second-Line Treatment After First-Line Failure

If Bismuth Quadruple Therapy Not Previously Used

  • Use the bismuth quadruple therapy regimen detailed above for 14 days 1, 2, 4

Levofloxacin Triple Therapy (If No Prior Fluoroquinolone Exposure)

  • PPI (high-dose): Twice daily 1, 2
  • Amoxicillin: 1000 mg twice daily 1, 2, 5
  • Levofloxacin: 500 mg once daily OR 250 mg twice daily 1, 2
  • Duration: 14 days 1, 2

Important warning: Levofloxacin resistance rates are rising (11-30% primary, 19-30% secondary), and the FDA recommends fluoroquinolones be used as a last choice due to serious side effects. 1, 2

Third-Line and Rescue Therapies

Rifabutin Triple Therapy

  • PPI (high-dose): Twice daily 1, 2
  • Amoxicillin: 1000 mg twice daily 1, 2, 5
  • Rifabutin: 150 mg twice daily 1, 2
  • Duration: 14 days 1, 2

Rifabutin resistance is extremely rare, making this an effective rescue option after multiple treatment failures. 1, 2

High-Dose Dual Amoxicillin-PPI Therapy

  • Amoxicillin: 2-3 grams daily in 3-4 divided doses 1, 2
  • PPI (high-dose): Double standard dose, twice daily 1, 2
  • Duration: 14 days 1, 2

This is reserved for patients who have exhausted other options. 1, 2

After Two Failed Attempts

  • Antibiotic susceptibility testing should guide further treatment whenever possible 1, 2, 4
  • Molecular testing for clarithromycin and levofloxacin resistance can guide therapy selection earlier 1

FDA-Approved Regimens for H. pylori (Adults)

Triple Therapy with Lansoprazole

  • Amoxicillin: 1 gram twice daily (every 12 hours) 5
  • Clarithromycin: 500 mg twice daily 5
  • Lansoprazole: 30 mg twice daily 5
  • Duration: 14 days 5

Dual Therapy with Lansoprazole

  • Amoxicillin: 1 gram three times daily (every 8 hours) 5
  • Lansoprazole: 30 mg three times daily 5
  • Duration: 14 days 5

Critical Optimization Factors

PPI Dosing

  • Always use high-dose PPI twice daily (not standard once-daily dosing), as this increases cure rates by 6-12% 1, 2
  • Esomeprazole or rabeprazole 40 mg twice daily are preferred over other PPIs, increasing cure rates by an additional 8-12% 1, 2
  • Take 30 minutes before meals on an empty stomach, without concomitant antacids 1, 2

Treatment Duration

  • 14 days is mandatory for all regimens, as it improves eradication success by approximately 5% compared to 7-10 day regimens 1, 2, 4

Antibiotic Selection

  • Never repeat antibiotics that failed previously, especially clarithromycin and levofloxacin, where resistance develops rapidly after exposure 1, 2
  • Amoxicillin and tetracycline can be re-used because resistance remains rare (<5%) 1, 2
  • Metronidazole can be re-used with bismuth because bismuth's synergistic effect overcomes in vitro resistance 1, 2

Special Populations

Penicillin Allergy

  • Bismuth quadruple therapy is the first choice, as it contains tetracycline, not amoxicillin 1, 2
  • Consider penicillin allergy testing to delist the allergy and enable amoxicillin use 1, 2

Renal Impairment (Amoxicillin Dosing)

  • GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours 5
  • GFR <10 mL/min: 500 mg or 250 mg every 24 hours 5
  • Hemodialysis: 500 mg or 250 mg every 24 hours, with additional dose during and at end of dialysis 5

Pediatric Patients (>3 months, <40 kg)

  • Amoxicillin: 45 mg/kg/day in divided doses every 12 hours (or 40 mg/kg/day every 8 hours) for severe infections 5
  • Avoid fluoroquinolones and tetracyclines in children 2
  • Treatment should only be conducted by pediatricians in specialist centers 1

Verification of Eradication

  • Confirm eradication with urea breath test or monoclonal stool antigen test at least 4 weeks after completion of therapy and at least 2 weeks after PPI discontinuation 1, 2, 4
  • Never use serology to confirm eradication, as antibodies persist long after successful treatment 1, 2

Common Pitfalls to Avoid

  • Inadequate PPI dosing: Standard once-daily PPI is inadequate; always use twice-daily high-dose PPI 1, 2
  • Assuming low clarithromycin resistance: Most regions now have resistance >15-20%; do not use triple therapy empirically without local surveillance data 1, 2
  • Repeating failed antibiotics: Avoid re-using clarithromycin or levofloxacin after exposure, as cross-resistance is universal 1, 2
  • Short treatment duration: 7-10 day regimens are inferior; always use 14 days 1, 2, 4

Adjunctive Measures

  • Probiotics can reduce antibiotic-associated diarrhea (occurs in 21-41% of patients) and improve compliance, though evidence for increasing eradication rates is limited 1, 2, 6
  • Smoking cessation should be encouraged, as smoking increases eradication failure risk (OR 1.95) 1
  • Address compliance issues, as >10% of patients are poor compliers, leading to much lower eradication rates 1

References

Guideline

Helicobacter Pylori Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Helicobacter pylori Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento de H. pylori con Subsalicilato de Bismuto

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Research

Management of Helicobacter pylori infection.

JGH open : an open access journal of gastroenterology and hepatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.